{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:07:38Z","timestamp":1787929658876,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81560562"],"award-info":[{"award-number":["81560562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Department of Guizhou Province","award":["QKHJC-ZK[2024]YB288"],"award-info":[{"award-number":["QKHJC-ZK[2024]YB288"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93076-4","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:21:09Z","timestamp":1741864869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["1, 4-benzodioxan-substituted Thienyl chalcone derivatives as novel reversible inhibitors of human monoamine oxidase B with anti-neuroinflammatory activity"],"prefix":"10.1038","volume":"15","author":[{"given":"Demeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"3","key":"93076_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham, K. J., Masters, C. L. & Bush, A. I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discovery. 3 (3), 205\u2013214. https:\/\/doi.org\/10.1038\/nrd1330 (2004).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"93076_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal. Transduct. Target. Therapy. 8 (1), 267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"1","key":"93076_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11033-023-08938-9","volume":"51","author":"JPS Niveta","year":"2023","unstructured":"Niveta, J. P. S., John, C. M. & Arockiasamy, S. Monoamine oxidase mediated oxidative stress: a potential molecular and biochemical crux in the pathogenesis of obesity. Mol. Biol. Rep. 51 (1), 29. https:\/\/doi.org\/10.1007\/s11033-023-08938-9 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"93076_CR4","doi-asserted-by":"publisher","first-page":"101256","DOI":"10.1016\/j.arr.2021.101256","volume":"66","author":"Y Santin","year":"2021","unstructured":"Santin, Y., Resta, J., Parini, A. & Mialet-Perez, J. Monoamine oxidases in age-associated diseases: new perspectives for old enzymes. Ageing Res. Rev. 66, 101256. https:\/\/doi.org\/10.1016\/j.arr.2021.101256 (2021).","journal-title":"Ageing Res. Rev."},{"key":"93076_CR5","doi-asserted-by":"publisher","first-page":"101957","DOI":"10.1016\/j.jchemneu.2021.101957","volume":"114","author":"DN Jones","year":"2021","unstructured":"Jones, D. N. & Raghanti, M. A. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J. Chem. Neuroanat. 114, 101957. https:\/\/doi.org\/10.1016\/j.jchemneu.2021.101957 (2021).","journal-title":"J. Chem. Neuroanat."},{"key":"93076_CR6","doi-asserted-by":"publisher","unstructured":"Ramsay, R. R. Molecular aspects of monoamine oxidase B. Progress in Neuro-Psychopharmacology and biological psychiatry. ;69:81\u201389. (2016). https:\/\/doi.org\/10.1016\/j.pnpbp.2016.02.005","DOI":"10.1016\/j.pnpbp.2016.02.005"},{"issue":"S1","key":"93076_CR7","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","volume":"147","author":"MBH Youdim","year":"2006","unstructured":"Youdim, M. B. H. & Bakhle, Y. S. Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br. J. Pharmacol. 147 (S1), S287\u2013S96. https:\/\/doi.org\/10.1038\/sj.bjp.0706464 (2006).","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"93076_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0306-4522(94)90311-5","volume":"62","author":"J Saura","year":"1994","unstructured":"Saura, J. et al. Increased monoamine oxidase B activity in plaque-associated astrocytes of alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62 (1), 15\u201330. https:\/\/doi.org\/10.1016\/0306-4522(94)90311-5 (1994).","journal-title":"Neuroscience"},{"key":"93076_CR9","doi-asserted-by":"publisher","first-page":"112787","DOI":"10.1016\/j.ejmech.2020.112787","volume":"206","author":"S Manzoor","year":"2020","unstructured":"Manzoor, S. & Hoda, N. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer\u2019s disease agents: A review. Eur. J. Med. Chem. 206, 112787. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112787 (2020).","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"93076_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"MBH Youdim","year":"2006","unstructured":"Youdim, M. B. H., Edmondson, D. & Tipton, K. F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7 (4), 295\u2013309. https:\/\/doi.org\/10.1038\/nrn1883 (2006).","journal-title":"Nat. Rev. Neurosci."},{"issue":"17","key":"93076_CR11","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1021\/jm501690r","volume":"58","author":"S Carradori","year":"2015","unstructured":"Carradori, S. & Silvestri, R. New frontiers in selective human MAO-B inhibitors. J. Med. Chem. 58 (17), 6717\u20136732. https:\/\/doi.org\/10.1021\/jm501690r (2015).","journal-title":"J. Med. Chem."},{"key":"93076_CR12","doi-asserted-by":"publisher","first-page":"104714","DOI":"10.1016\/j.neuint.2020.104714","volume":"136","author":"AP de Ara\u00fajo Boleti","year":"2020","unstructured":"de Ara\u00fajo Boleti, A. P. et al. An overview of neurodegenerative and metabolic diseases and of biotechnological studies. Neurochem. Int. 136, 104714. https:\/\/doi.org\/10.1016\/j.neuint.2020.104714 (2020).","journal-title":"Neurochem. Int."},{"issue":"4","key":"93076_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14 (4), 388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5 (2015).","journal-title":"Lancet Neurol."},{"issue":"3","key":"93076_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in alzheimer disease: where do we go from here? Nat. Reviews Neurol. 17 (3), 157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y (2021).","journal-title":"Nat. Reviews Neurol."},{"issue":"1","key":"93076_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao, C., Jiang, J., Tan, Y. & Chen, S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal. Transduct. Target. Therapy. 8 (1), 359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"93076_CR16","doi-asserted-by":"publisher","first-page":"112650","DOI":"10.1016\/j.ejmech.2020.112650","volume":"205","author":"P Guglielmi","year":"2020","unstructured":"Guglielmi, P., Mathew, B., Secci, D., Carradori, S. & Chalcones Unearthing their therapeutic possibility as monoamine oxidase B inhibitors. Eur. J. Med. Chem. 205, 112650. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112650 (2020).","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"93076_CR17","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/jm801590u","volume":"52","author":"F Chimenti","year":"2009","unstructured":"Chimenti, F. et al. Chalcones: a valid scaffold for monoamine oxidases inhibitors. J. Med. Chem. 52 (9), 2818\u20132824. https:\/\/doi.org\/10.1021\/jm801590u (2009).","journal-title":"J. Med. Chem."},{"key":"93076_CR18","doi-asserted-by":"publisher","first-page":"103335","DOI":"10.1016\/j.bioorg.2019.103335","volume":"93","author":"DGT Parambi","year":"2019","unstructured":"Parambi, D. G. T. et al. Design, synthesis and biological evaluation of oxygenated Chalcones as potent and selective MAO-B inhibitors. Bioorg. Chem. 93, 103335. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103335 (2019).","journal-title":"Bioorg. Chem."},{"issue":"22","key":"93076_CR19","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1016\/j.bmcl.2015.09.049","volume":"25","author":"C Minders","year":"2015","unstructured":"Minders, C., Petzer, J. P., Petzer, A. & Lourens, A. C. Monoamine oxidase inhibitory activities of heterocyclic Chalcones. Bioorg. Med. Chem. Lett. 25 (22), 5270\u20135276. https:\/\/doi.org\/10.1016\/j.bmcl.2015.09.049 (2015).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"93076_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ijbiomac.2016.05.110","volume":"91","author":"B Mathew","year":"2016","unstructured":"Mathew, B. et al. Exploration of chlorinated Thienyl Chalcones: A new class of monoamine oxidase-B inhibitors. Int. J. Biol. Macromol. 91, 680\u2013695. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.05.110 (2016).","journal-title":"Int. J. Biol. Macromol."},{"issue":"23","key":"93076_CR21","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1021\/jm200946h","volume":"54","author":"J Wu","year":"2011","unstructured":"Wu, J. et al. Evaluation and discovery of novel synthetic chalcone derivatives as Anti-Inflammatory agents. J. Med. Chem. 54 (23), 8110\u20138123. https:\/\/doi.org\/10.1021\/jm200946h (2011).","journal-title":"J. Med. Chem."},{"issue":"1","key":"93076_CR22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1080\/14756366.2020.1797711","volume":"35","author":"Z Kong","year":"2020","unstructured":"Kong, Z., Sun, D., Jiang, Y. & Hu, Y. Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted Chalcones as selective and reversible inhibitors of human monoamine oxidase B. J. Enzyme Inhib. Med. Chem. 35 (1), 1513\u20131523. https:\/\/doi.org\/10.1080\/14756366.2020.1797711 (2020).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"14","key":"93076_CR23","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1021\/jm400567s","volume":"56","author":"C Lu","year":"2013","unstructured":"Lu, C. et al. Design, synthesis, and evaluation of Multitarget-Directed Resveratrol derivatives for the treatment of Alzheimer\u2019s disease. J. Med. Chem. 56 (14), 5843\u20135859. https:\/\/doi.org\/10.1021\/jm400567s (2013).","journal-title":"J. Med. Chem."},{"issue":"6","key":"93076_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/acsmedchemlett.3c00532","volume":"15","author":"D Sun","year":"2024","unstructured":"Sun, D. et al. Benzodioxane Carboxamide derivatives as novel monoamine oxidase B inhibitors with antineuroinflammatory activity. ACS Med. Chem. Lett. 15 (6), 798\u2013805. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00532 (2024).","journal-title":"ACS Med. Chem. Lett."},{"key":"93076_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejmech.2017.04.055","volume":"135","author":"S Mostert","year":"2017","unstructured":"Mostert, S., Petzer, A. & Petzer, J. P. The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase. Eur. J. Med. Chem. 135, 196\u2013203. https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.055 (2017).","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"93076_CR26","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"C Binda","year":"2007","unstructured":"Binda, C. et al. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs. J. Med. Chem. 50 (23), 5848\u20135852. https:\/\/doi.org\/10.1021\/jm070677y (2007).","journal-title":"J. Med. Chem."},{"key":"93076_CR27","doi-asserted-by":"publisher","unstructured":"Son, S-Y. et al. Structure of human monoamine oxidase A at 2.2-\u00c5 resolution: The control of opening the entry for substrates\/inhibitors. Proceedings of the National Academy of Sciences. ;105(15):5739-44. (2008). https:\/\/doi.org\/10.1073\/pnas.0710626105","DOI":"10.1073\/pnas.0710626105"},{"key":"93076_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejmech.2011.12.027","volume":"48","author":"S Distinto","year":"2012","unstructured":"Distinto, S. et al. Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B. Eur. J. Med. Chem. 48, 284\u2013295. https:\/\/doi.org\/10.1016\/j.ejmech.2011.12.027 (2012).","journal-title":"Eur. J. Med. Chem."},{"key":"93076_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejmech.2018.02.063","volume":"149","author":"Y Fang","year":"2018","unstructured":"Fang, Y. et al. Design, synthesis, and biological evaluation of compounds with a new scaffold as anti-neuroinflammatory agents for the treatment of Alzheimer\u2019s disease. Eur. J. Med. Chem. 149, 129\u2013138. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.063 (2018).","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"93076_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bmc.2016.11.048","volume":"25","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Multitarget drug design strategy against Alzheimer\u2019s disease: homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties. Bioorg. Med. Chem. 25 (2), 714\u2013726. https:\/\/doi.org\/10.1016\/j.bmc.2016.11.048 (2017).","journal-title":"Bioorg. Med. Chem."},{"issue":"36","key":"93076_CR31","doi-asserted-by":"publisher","first-page":"12684","DOI":"10.1073\/pnas.0505975102","volume":"102","author":"L De Colibus","year":"2005","unstructured":"De Colibus, L. et al. Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc. Natl. Acad. Sci. 102 (36), 12684\u201312689. https:\/\/doi.org\/10.1073\/pnas.0505975102 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"93076_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioorg.2012.08.003","volume":"45","author":"LJ Legoabe","year":"2012","unstructured":"Legoabe, L. J., Petzer, A. & Petzer, J. P. Selected C7-substituted Chromone derivatives as monoamine oxidase inhibitors. Bioorg. Chem. 45, 1\u201311. https:\/\/doi.org\/10.1016\/j.bioorg.2012.08.003 (2012).","journal-title":"Bioorg. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93076-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93076-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93076-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:21:14Z","timestamp":1741864874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93076-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93076"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93076-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8690"}}